ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 심장 이식 시장 규모는 향후 몇 년간 강력한 성장이 예상됩니다. 예측기간의 성장은 정부의 지원과 자금 제공, 이식 프로그램의 세계와, 이식 센터의 능력 향상, 원격 의료와 원격 모니터링의 통합 등에 기인하고 있습니다. 예측 기간의 주요 동향에는 기술의 진보, 인공 심장과 보조 장치, 기증자 장기 선택에서의 인공지능(AI) 등이 있습니다.
심혈관 질환의 유병률 증가는 향후 몇 년동안 심장 이식 시장의 성장을 가속할 것으로 예상됩니다. 심장 이식은 다른 치료법에 반응하지 않는 말기 심부전 환자의 마지막 치료법입니다. 생활의 질을 대폭 개선해, 수명을 연장합니다. 예를 들어 2024년 9월, 영국에 본사를 둔 심장혈관 연구 자선단체인 British Heart Foundation은 현재 영국에서 약 760만명이 심장 및 순환기 질환을 앓고 있으며, 그 내역은 남성 400만명, 여성 360만명이라고 보고했습니다. 이 숫자는 2030년까지 100만명 증가할 것으로 예상되며, 2040년까지 추가로 200만명 증가할 가능성이 있습니다.
심장 이식 시장은 장기 제공과 이식에 대한 의식 증가로 성장을 이루고 있습니다. 이러한 의식의 성장은 심장 이식 영역에서 중요한 역할을 하고 있으며, 공여자 풀의 확대, 수혜자의 대기 시간의 단축, 환자의 결과의 개선으로 연결되고 있습니다. 예를 들어, 2023년 1월, 미국에 본사를 둔 과학과 교육에 중점을 둔 비영리 단체 United Network for Organ Sharing에 따르면 2022년 미국에서의 장기 이식 건수는 42,887건으로 전년부터 3.7% 증가했다고 보고했습니다. 그 결과, 장기 제공이나 이식에 대한 의식의 고조가, 심장 이식 시장의 주요한 촉진요인이 되고 있습니다. 그 내역은 간 이식이 9,528건, 심장 이식이 4,111건, 폐 이식이 2,692건이었습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 심장 이식 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 심장 이식 시장 : 성장률 분석
세계의 심장 이식 시장 실적 : 규모와 성장, 2019-2024
세계의 심장 이식 시장 예측 : 규모와 성장, 2024-2029년, 2034F
세계의 심장 이식 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 심장 이식 시장 : 수술 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
완전 인공 심장
양심실 페이싱
보조 인공 심장
기타 수술의 유형
세계의 심장 이식 시장 : 이식별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
자가이식
동종이식
기타 이식
세계의 심장 이식 시장 : 최종 사용자별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
병원
심장병 연구소
기타 최종 사용자
세계의 심장 이식 시장 : 인공 심장 유형별 세분화, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
일시적인 완전 인공 심장
영구 완전 인공 심장
세계의 심장 이식 시장 : 양심실 페이싱 유형별 세분화, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
심장 재동기 치료 페이스메이커(CRT-P)
심장 재동기 요법 제세동기(CRT-D)
세계의 심장 이식 시장 : 보조 인공 심장별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
좌심실 보조 장치(LVAD)
우심실 보조 장치(RVAD)
양심실 보조 장치(BIVAD)
세계의 심장 이식 시장 : 기타 수술 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
심장과 폐의 이식
이소성 심장 이식
제7장 지역별 및 국가별 분석
세계의 심장 이식 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 심장 이식 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
심장 이식 시장 : 경쟁 구도
심장 이식 시장 : 기업 프로파일
Optum Inc. : 개요, 상품 및 서비스, 전략 및 재무분석
Novartis Pharmaceuticals UK Ltd. : 개요, 상품 및 서비스, 전략 및 재무분석
Abbott Laboratories : 개요, 상품 및 서비스, 전략 및 재무분석
Medtronic plc : 개요, 상품 및 서비스, 전략 및 재무분석
Stryker Corporation : 개요, 상품 및 서비스, 전략 및 재무분석
제31장 기타 주요 기업 및 혁신 기업
Roche Diagnostics Ltd.
Mayo Clinic
Cleveland Clinic
AstraZeneca plc
Massachusetts General Hospital
Terumo Corp.
NewYork-Presbyterian Hospital
Cedars-Sinai Medical Center
Maquet Holding BV and Co. KG.
Teleflex Inc.
Stanford Health Care
Johns Hopkins Hospital
Thoratec Corporation
Abiomed Inc.
Baylor St. Lukes Medical Center
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
심장 이식 시장(2029년) : 새로운 기회를 제공하는 국가
심장 이식 시장(2029년) : 새로운 기회를 제공하는 부문
심장 이식 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
A heart transplant is a sophisticated surgical procedure in which a damaged or diseased heart is removed and replaced with a healthy donor heart. This intervention is crucial and can be life-saving for individuals suffering from end-stage heart failure or specific severe heart conditions.
There are several types of heart transplant surgeries, including total artificial heart, biventricular pacing, ventricular assist devices, and other specialized procedures. A total artificial heart is a mechanical device specifically engineered to take over the functions of both the left and right ventricles of the natural human heart. This category encompasses various transplant techniques like autografts, allografts, and others. The primary recipients of these procedures are hospitals, cardiac institutes, and other specialized medical facilities.
The heart transplant market research report is one of a series of new reports from The Business Research Company that provides heart transplant market statistics, including heart transplant industry global market size, regional shares, competitors with a heart transplant market share, detailed heart transplant market segments, market trends and opportunities and any further data you may need to thrive in the heart transplant industry. This heart transplant market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The heart transplant market size has grown rapidly in recent years. It will grow from $11.49 billion in 2024 to $12.66 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to medical advancements, increased awareness and education, advancements in organ preservation, healthcare infrastructure.
The heart transplant market size is expected to see strong growth in the next few years. It will grow to $18.1 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to government support and funding, globalization of transplant programs, increasing transplant center capacity, integration of telemedicine and remote monitoring. Major trends in the forecast period include technological advancements, artificial heart and assist devices, artificial intelligence (AI) in donor organ selection.
The increasing prevalence of cardiovascular diseases is expected to drive the growth of the heart transplant market in the coming years. Cardiovascular diseases encompass a range of conditions that affect the heart and blood vessels. A heart transplant is a treatment of last resort for individuals with end-stage heart failure who have not responded to other therapies. It significantly improves the quality of life and extends life expectancy. For example, in September 2024, the British Heart Foundation, a UK-based cardiovascular research charity, reported that approximately 7.6 million people in the UK are currently affected by heart and circulatory diseases, including 4 million men and 3.6 million women. This number is expected to increase by 1 million by 2030 and could rise by an additional 2 million by 2040. As a result, the growing prevalence of cardiovascular diseases will drive the heart transplant market.
The heart transplant market is experiencing growth driven by an increased awareness of organ donation and transplantation. This awareness encompasses knowledge, understanding, and community consciousness regarding the processes, significance, and impact of these procedures in healthcare. This heightened awareness is playing a substantial role in the realm of heart transplants, leading to an expanded donor pool, reduced waiting times for recipients, and improved patient outcomes. For instance, in January 2023, the United Network for Organ Sharing, a US-based non-profit organization focused on science and education, reported a record of 42,887 organ transplants in the US in 2022, marking a 3.7% increase from the previous year. This included 9,528 liver transplants, 4,111 heart transplants, and 2,692 lung transplants, underscoring the impact of this growing awareness. Consequently, the surge in awareness about organ donation and transplantation is a key driver for the heart transplant market.year. This included 9,528 liver transplants, 4,111 heart transplants, and 2,692 lung transplant. Therefore, the growing awareness about organ donation and transplantation will drive the heart transplant market.
Major companies in the heart transplant market are increasingly focused on developing innovative solutions, such as heart preservation technology, to enhance patient outcomes and improve transplant success rates. This technology significantly extends the preservation time of the heart outside the body compared to traditional ice storage, leading to better outcomes and reduced complications after transplantation. For instance, in May 2023, Xvivo Perfusion AB, a Sweden-based medical technology company, received approval from the U.S. Food and Drug Administration (FDA) for its Investigational Device Exemption (IDE) application for heart preservation technology. This approval enabled the company to launch the "PRESERVE Clinical Trial," a prospective, multicenter, single-arm, open-label study focused on evaluating hearts transplanted after non-ischemic heart preservation from extended donors, including those from Donation after Circulatory Death (DCD). The key feature of Xvivo's heart preservation technology is its non-ischemic hypothermic perfusion system, which uses cold, oxygenated perfusion to preserve donor hearts during transport.
In August 2024, Getinge, a Sweden-based company specializing in medical technology and healthcare solutions, acquired Paragonix Technologies for an undisclosed amount. This acquisition allows Getinge to strengthen its capabilities in organ preservation and transportation, with a focus on improving patient outcomes in transplant procedures. Paragonix Technologies, a U.S.-based company, designs, manufactures, and sells devices used for the transport of organs for transplant.
Major companies operating in the heart transplant market are Optum Inc., Novartis Pharmaceuticals UK Ltd., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Roche Diagnostics Ltd., Mayo Clinic, Cleveland Clinic, AstraZeneca PLC, Massachusetts General Hospital, Terumo Corp., NewYork-Presbyterian Hospital, Cedars-Sinai Medical Center, Maquet Holding B.V. and Co. KG., Teleflex Inc., Stanford Health Care, Johns Hopkins Hospital, Thoratec Corporation, Abiomed Inc., Baylor St. Lukes Medical Center, Transonic Systems Inc., Berlin Heart GmbH, HeartWare International Inc., SynCardia Systems LLC., Carmat SA, BiVACOR Inc., Apaxis Medical Inc., Calon Cardio-Technology Ltd., CardiacAssist Inc., The Texas Heart Institute.
North America was the largest region in the heart transplant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in heart transplant report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the heart transplant market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The heart transplant market includes revenues earned by entities by providing services such as patient evaluation and selection, waitlist management, donor heart procurement, transplant surgery, immunosuppression management, psychosocial support and complications management services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Heart Transplant Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on heart transplant market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for heart transplant ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The heart transplant market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Surgery Type: Total Artificial Heart; Biventricular Pacing; Ventricular Assist Devices; Other Surgery Types
2) By Transplant: Autograft; Allograft; Other Transplants
3) By End-User: Hospitals; Cardiac Institutes; Other End-Users
Subsegments:
1) By Total Artificial Heart: Temporary Total Artificial Heart; Permanent Total Artificial Heart
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Heart Transplant Market Characteristics
3. Heart Transplant Market Trends And Strategies
4. Heart Transplant Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Heart Transplant Growth Analysis And Strategic Analysis Framework
5.1. Global Heart Transplant PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Heart Transplant Market Growth Rate Analysis
5.4. Global Heart Transplant Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Heart Transplant Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Heart Transplant Total Addressable Market (TAM)
6. Heart Transplant Market Segmentation
6.1. Global Heart Transplant Market, Segmentation By Surgery Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Total Artificial Heart
Biventricular Pacing
Ventricular Assist Devices
Other Surgery Types
6.2. Global Heart Transplant Market, Segmentation By Transplant, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Autograft
Allograft
Other Transplants
6.3. Global Heart Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Cardiac Institutes
Other End-Users
6.4. Global Heart Transplant Market, Sub-Segmentation Of Total Artificial Heartl, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Temporary Total Artificial Heart
Permanent Total Artificial Heart
6.5. Global Heart Transplant Market, Sub-Segmentation Of Biventricular Pacing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
6.6. Global Heart Transplant Market, Sub-Segmentation Of Ventricular Assist Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)
6.7. Global Heart Transplant Market, Sub-Segmentation Of Other Surgery Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Heart And Lung Transplant
Heterotopic Heart Transplant
7. Heart Transplant Market Regional And Country Analysis
7.1. Global Heart Transplant Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Heart Transplant Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
